# Bacopa Cognitive Performance Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/bacopa-cognitive-performance-randomized-trial-evidence-review
Category: evidence-review
Summary: Bacopa Cognitive Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa
Last reviewed: 2026-07-06
Reviewed by: Migaku Evidence Review
# Bacopa Cognitive Performance Randomized Trial: What the Evidence Says

## Quick Answer

Bacopa Cognitive Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial | randomized trial | 2 | 2026-01-01 | 10.2196/82891 |
| Phytochemical Profile, Antioxidant Activity, and Neuroprotective Effects of Bacopa monnieri Extract in a Lipopolysaccharide-Induced Dementia Model | research article | 4 | 2026-06-09 | 10.3390/ijms27125229 |

## What The Sources Report

- There was heterogeneity in dosage, duration, formulation, follow-up, and outcomes, and the overall quality of evidence was very low due to high risk of bias, small sample size, and wide CIs. [Dwivedi Abhilasha (2026); evidence level 2]
- New evidence shows that the gut-brain axis is a crucial modulator: intestinal dysbiosis and increased gut permeability may allow bacterial components (including lipopolysaccharide, LPS) and other metabolites to enter the circulation, triggering systemic inflammation and microglial activation in the brain. [Olajide Abosede Temitope (2026); evidence level 4]
- In addition, the oxygen radical antioxidant capacity (ORAC) assay revealed free radical scavenging capacity of 1.17 ± 0.01 µM TE/mg extract.C,D also shows the kinetic fluorescence decay curves of fluorescein and the net area under the curve (AUC), which also gives additional evidence on the antioxidant potential of the extract. [Olajide Abosede Temitope (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For bacopa cognitive performance randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Dwivedi Abhilasha (2026). Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial. DOI: 10.2196/82891. PMCID: PMC12935425. PMID: 41740144. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12935425/
- Olajide Abosede Temitope (2026). Phytochemical Profile, Antioxidant Activity, and Neuroprotective Effects of Bacopa monnieri Extract in a Lipopolysaccharide-Induced Dementia Model. DOI: 10.3390/ijms27125229. PMCID: PMC13299668. PMID: 42352952. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13299668/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.